Comparison Chart SOPHiA GENETICS SA Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.400 EUR | -0.92% |
|
+8.43% | +39.18% |
| 08-05 | SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SOPHIA GENETICS SA | Medical Software & Technology Services | -0.92% | +8.43% | +39.18% | +45.95% | - | 536M |
-
|
-
|
-
|
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
- Charts SOPHiA GENETICS SA
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
